Swiss National Bank Trims Holdings in Envista Holdings Co. (NYSE:NVST)

Swiss National Bank reduced its holdings in shares of Envista Holdings Co. (NYSE:NVST) by 0.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 335,400 shares of the company’s stock after selling 3,100 shares during the period. Swiss National Bank owned 0.19% of Envista worth $6,628,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its holdings in shares of Envista by 6.7% during the first quarter. Price T Rowe Associates Inc. MD now owns 133,887 shares of the company’s stock valued at $2,863,000 after purchasing an additional 8,380 shares during the last quarter. Tidal Investments LLC raised its stake in Envista by 105.1% during the first quarter. Tidal Investments LLC now owns 20,331 shares of the company’s stock valued at $435,000 after buying an additional 10,420 shares during the last quarter. Swedbank AB bought a new stake in Envista in the first quarter worth $53,412,000. Versant Capital Management Inc grew its stake in shares of Envista by 1,420.3% in the second quarter. Versant Capital Management Inc now owns 3,147 shares of the company’s stock worth $52,000 after acquiring an additional 2,940 shares during the last quarter. Finally, Harbor Capital Advisors Inc. increased its holdings in shares of Envista by 287.4% during the second quarter. Harbor Capital Advisors Inc. now owns 169,648 shares of the company’s stock valued at $2,821,000 after acquiring an additional 125,861 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and upped their price target for the stock from $16.00 to $23.00 in a research note on Thursday, October 31st. Leerink Partnrs upgraded shares of Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Bank of America cut their price target on shares of Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 8th. Evercore ISI boosted their price objective on shares of Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Finally, Wells Fargo & Company initiated coverage on Envista in a report on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 target price for the company. One analyst has rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $20.71.

Envista Price Performance

Envista stock opened at $22.00 on Wednesday. Envista Holdings Co. has a 52-week low of $15.15 and a 52-week high of $25.64. The company has a quick ratio of 1.77, a current ratio of 2.08 and a debt-to-equity ratio of 0.42. The firm’s fifty day moving average is $19.61 and its 200 day moving average is $18.21. The company has a market cap of $3.79 billion, a price-to-earnings ratio of -2.83, a PEG ratio of 2.99 and a beta of 1.30.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.03. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The business had revenue of $601.00 million during the quarter, compared to analyst estimates of $590.34 million. During the same period last year, the company earned $0.43 EPS. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. Sell-side analysts forecast that Envista Holdings Co. will post 0.72 EPS for the current fiscal year.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.